ATEA PHARMACEUTICALS INC (AVIR)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for AVIR
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| AVIR | Independent Director | 61 | ["Over three decades of experience in the life science industry","Experience in academia, pharmaceutical and biopharmaceutical companies","Expertise in commercial development, strategic planning, R&D, and business development","Leadership positions at Pfizer","Chief Business Officer at Avadel Pharmaceuticals plc","Chief Business Officer at UroGen Pharmaceuticals, Inc.","Multiple leadership roles at Pfizer, Inc.","SVP, Business and Scientific Services at The Scripps Research Institute"] | ["Nominating and Corporate Governance (Chair)","Strategy and Public Policy"] | 2026 |
Biography sourced from the proxy statement filing.
Independent Director Age: 61 Director Since: 2020 Class: II Committee Memberships Nominating and Corporate Governance (Chair) Strategy and Public Policy Education Iowa State University, DVM Iowa State University, PhD Nova Southeastern University, MBA Qualifications and Expertise Provided to Our Board Dr. Murphy provides the Board with a unique and comprehensive perspective, drawing from more than three decades of experience in the life science industry, including experience in each of academia, pharmaceutical and biopharmaceutical companies. Her expertise spans commercial development, strategic planning, R&D, and business development, honed through leadership positions at Pfizer and experience at biopharmaceutical companies. Notably, Dr. Murphy s success in pipeline development and commercialization at Pfizer underscores her strategic acumen. Professional Experience Chief Business Officer at Avadel Pharmaceuticals plc , a biopharmaceutical company, where she directed the company s strategy, business development and new product planning efforts (2024-2026) Chief Business Officer at UroGen Pharmaceuticals, Inc. , tasked with leading commercial development, business development and strategy for in-line and pipeline medicines (2020-2024) Leadership roles at Pfizer, Inc. , including: o Head of Oncology Early Commercial Development (2019-2020) o Head of Oncology Global Marketing and Commercial Development (2017-2018) o Head of Strategy and Business Development in China (2013-2017) o From 2008-2013, Dr. Murphy held multiple business development roles with increasing responsibilities, including VP, Worldwide R&D Business Development (2009-2012) SVP, Business and Scientific Services at The Scripps Research Institute , responsible for licensing, commercialization and business development (2005-2008) Other Public Company Directorships (past five years): Celcuity, Inc. (Ticker: CELC), 2022-present Core Skills Drug Development / Scientific Experience Life Sciences / Healthcare Industry Business Development / Strategic Partnerships Finance & Audit M&A / Strategic Investment Senior Executive Role Corporate Governance